{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2017"],"condition":["Lymphoma, T-Cell","Refractory Adult T-Cell Leukemia/Lymphoma","Leukemia","NK-Cell Lymphoma, Unclassifiable","Lymphoma, T-Cell, Peripheral","Mycoses","Refractory Enteropathy-Associated T-Cell Lymphoma","Blastic Plasmacytoid Dendritic Cell Neoplasm","Refractory Angioimmunoblastic T-cell Lymphoma","Leukemia, T-Cell","Lymphoma, Non-Hodgkin","Recurrent Angioimmunoblastic T-cell Lymphoma","Mycosis Fungoides","Refractory Nasal Type Extranodal NK/T-Cell Lymphoma","Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified","HTLV-1 Infection","Refractory Anaplastic Large Cell Lymphoma","Leukemia-Lymphoma, Adult T-Cell","Enteropathy-Associated T-Cell Lymphoma","Hepatosplenic T-Cell Lymphoma","Recurrent Adult T-Cell Leukemia/Lymphoma","Recurrent Mycosis Fungoides","Immunoblastic Lymphadenopathy","Intestinal Diseases","Refractory Mycosis Fungoides","Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative","Recurrent Enteropathy-Associated T-Cell Lymphoma","Lymphoma","Recurrent Anaplastic Large Cell Lymphoma","Lymphoma, Extranodal NK-T-Cell","Lymphoma, Large-Cell, Anaplastic"],"disease":["Leukemia","Mycoses","Refractory Nasal Type Extranodal Nk/t-cell Lymphoma","Blastic Plasmacytoid Dendritic Cell Neoplasm","Refractory Angioimmunoblastic T-cell Lymphoma","Refractory Enteropathy-associated T-cell Lymphoma","Lymphoma, Large-cell, Anaplastic","Recurrent Angioimmunoblastic T-cell Lymphoma","Mycosis Fungoides","Leukemia-lymphoma, Adult T-cell","Lymphoma, T-cell","Primary Systemic Anaplastic Large Cell Lymphoma, Alk-negative","Leukemia, T-cell","Refractory Peripheral T-cell Lymphoma, Not Otherwise Specified","Refractory Anaplastic Large Cell Lymphoma","Hepatosplenic T-cell Lymphoma","Lymphoma, T-cell, Peripheral","Recurrent Mycosis Fungoides","Refractory Adult T-cell Leukemia/lymphoma","Immunoblastic Lymphadenopathy","Lymphoma, Extranodal Nk-t-cell","Refractory Mycosis Fungoides","Intestinal Diseases","Lymphoma","Recurrent Anaplastic Large Cell Lymphoma","Enteropathy-associated T-cell Lymphoma","Htlv-1 Infection","Recurrent Enteropathy-associated T-cell Lymphoma","Recurrent Adult T-cell Leukemia/lymphoma","Lymphoma, Non-hodgkin","Nk-cell Lymphoma, Unclassifiable"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2238422"],"location":["United States"],"study_start_month":["5"],"keyword":["Nivolumab"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma","description":"This phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a period of improvement or that does not respond to treatment. Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells.","dates":{"creation":"2017-05-15"},"accession":"2238422","cross_references":{"ClinicalTrials___gov":["NCT03075553"]}}